Suppression of myeloid PFKFB3-driven glycolysis protects mice from choroidal neovascularization.
Zhiping LiuXiaoxiao MaoQiuhua YangXiaoyu ZhangJiean XuQian MaYaqi ZhouQingen DaYongfeng CaiAnu SopeyinZheng DongMei HongRuth B CaldwellAkrit SodhiYuqing HuoPublished in: British journal of pharmacology (2022)
Modulation of PFKFB3-mediated macrophage glycolysis and activation is a promising strategy for the treatment of nAMD.